TREATMENT COSTS EVALUATION FOR DRUG SUSCEPTIBLE AND DRUG RESISTANT TUBERCULOSIS PATIENTS IN THE UNITS OF TOMSK REGIONAL TB SERVICES
Abstract
Basing on the data of capital expenses and current costs of Tomsk TB Service in 2011, prime costs of 1 month of treatment of a tuberculosis case in various units of TB Service were evaluated. The prime costs of treatment in the in-patient department as per the 1st, 2nd and 3rd regimens made 23,837 RUR per month and it was 89% higher than the cost of treatment in the day hospital (12,612 RUR), and by 173% higher than the treatment in the polyclinic (8,722 RUR), by 145% than treatment at home (9,717 RUR) and by 91% than treatment within the Sputnik program (12,499 RUR). Treatment as per the 4th regimen turned out to be the most expensive in the in-patient hospital (29,880 RUR) exceeding by 55% the treatment cost in the day center (19,336 RUR), by 112% – in the polyclinic (14,107 RUR), by 71% – treatment at home (17,512 RUR), and by 29% – Sputnik program (23,207 RUR).
About the Authors
I. E. Gel'manova
Non-governmental organization Partners in Health, Boston
Russian Federation
Tomsk
Russian Federation
Tomsk
N. A. Zemlyanaya
Non-governmental organization Partners in Health;
Siberian State Medical University
Russian Federation
Russian Federation
Tomsk
L. V. Khon
Tomsk Regional Hospital
Russian Federation
Tomsk
Russian Federation
Tomsk
E. A. Kruk
Tomsk Phthisiopulmonology Medical Center
Russian Federation
Tomsk
Russian Federation
Tomsk
S. P. Mishustin
Tomsk Phthisiopulmonology Medical Center
Russian Federation
Tomsk
Russian Federation
Tomsk
G. V. Yanova
Siberian State Medical University
Russian Federation
Tomsk
Russian Federation
Tomsk
References
1. Kasaeva T.Ch., Sterlikov S.А., Son I.M. et al.: Otraslevye i ekonomicheskye pokazateli protivotuberkuleznoy raboty v 2012-2013 gg. Analitichesky obzor osnovnykh pokazateley i statisticheskiye materialy. [Economic rates for TB control in 2012-2013. Analysis of main rates and statistic materials]. Moscow, RIO TsNIIOIZ Publ., 2014, 72 p. (Epub). Available at: http://www.mednet.ru/ru/czentr-monitoringa-tuberkuleza/produkcziya-czentra/sborniki.html (Accessed as of 23.03.2015)
2. Novosibirsk Research Institute of Tuberculosis. Diagnosticheskiy tsentr. Laboratornaya diagnostika. [Diagnostic Center. Laboratory diagnostics]. (Epub.), Available at: http://nsk-niit.ru/ru/katalog/punkty-priema-pacientov/perechen-issledovanij-po-gruppam
3. Taran D.V., Gelmanova I.E., Solovieva А.V. et al. Organization of directly observed treatment for tuberculosis patients in Tomsk Region with the help of Sputnik initiative. Tub., 2013, no. 1, pp. 21-27. (In Russ.)
4. Tuberkulez v Rossijskoy Federatsii 2011 g. Аnaliticheskiy obzor statisticheskikh pokazateley, ispol’zuemykh v Rossiyskoy Federatsii i v mire. [Tuberculosis in the Russian Federation in 2011. Analytic review of statistic rates used in the Russian Federation and in the world]. Moscow, 2013.
5. Dharmadhikari A.S., Mphahlele M., Venter K. et al. Rapid impact of effective treatment on transmission of multidrug-resistant tuberculosis. Int. J. Tuberc. Lung Dis., 2014, vol. 18, no. 9, pp. 1019-1025.
6. Dobler C.C., Korver S., Batbayar O. et al. Success of community-based directly observed anti-tuberculosis treatment in Mongolia. Int. J. Tuberc. Lung Dis., 2015, vol. 19, no. 6, pp. 657-662.
7. Gärden B., Samarina A., Stavchanskaya I.et al. Food incentives improve adherence to tuberculosis drug treatment among homeless patients in Russia. Scand. J. Caring Sci., 2013, vol. 27, no. 1, pp. 117-122.
8. Loveday M., Wallengren K., Brust J. et al. Community-based care vs. centralisedhospitalisation for MDR-TB patients, KwaZulu-Natal, South Africa. Int. J. Tuberc. Lung Dis., 2015, vol. 19, no. 2, pp. 163-171.
9. Mitnick C., Bayona J., Palacios E. et al. Community-based therapy for multi-drug resistant tuberculosis in Lima, Peru. N. Engl. J. Med., 2003, vol. 34, pp. 119-128.
10. Mkopi A., Range N., Lwilla F. et al. Adherence totuberculosis therapyamong patients receiving home-based directly observedtreatment: evidence from the United Republic of Tanzania. PLoS One, 2012, vol. 7, no. 12,
11. Toczek A. et al. Strategies for reducing treatment default in drug-resistant tuberculosis: a systematic review and meta-analysis. Int. J. Tuberc. Lung Disease, 2013, vol. 17, no. 3, pp. 299-307.
Review
For citations:
Gel'manova I.E., Zemlyanaya N.A., Khon L.V., Kruk E.A., Mishustin S.P., Yanova G.V. TREATMENT COSTS EVALUATION FOR DRUG SUSCEPTIBLE AND DRUG RESISTANT TUBERCULOSIS PATIENTS IN THE UNITS OF TOMSK REGIONAL TB SERVICES. Tuberculosis and Lung Diseases. 2016;94(3):20-27. (In Russ.)
Views:
665
Email this article 